University of Leicester
Leicester, Leicestershire, Le1 7rh, United Kingdom
NCT Number: NCT04342481
Peripheral arterial disease (PAD) occurs when the vessels carrying blood to the legs become narrowed or blocked. It affects 1 in 5 people aged over 60 and are at risk of losing their leg, developing a heart attack or stroke, or die early.
Early symptoms of peripheral arterial disease (PAD) include aching in the legs when walking which may not be recognised by healthcare professional. Our research has shown that knowledge and recognition of PAD is poor in healthcare professionals and trainees. There appears to be little time provided within healthcare professional training for PAD.
To improve PAD recognition/management, the investigators want to identify the current level of training given to healthcare professionals; opinion towards PAD related to their training and how they prefer to receive training.
With the information gained from this research, the development of an educational training package for GPs, practice nurses and their trainees to improve recognition of PAD is anticipated.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Leicester, Leicestershire, Le1 7rh, United Kingdom
Around 20% of people above 60 years are estimated to have PAD. The prevalence of PAD is expected to rise due to a sedentary life-style, poor dietary choices, rising prevalence of diabetes and longer life-expectancy.
The most common presentation of symptomatic PAD is intermittent claudication - pain on activity. In some cases the reduction in blood flow is so severe that it causes pain at rest, ulceration or gangrene (chronic limb threatening ischemia, CLTI). Approximately 5% of individuals between the age of 55 and 74 in the UK have IC or CLTI. Compared to age-matched individuals, these patients are more likely to suffer cardiovascular events - heart attack and strokes and cognitive impairment (10). Of those with IC, 5% will progress to CLTI. In patients with CLTI the one-year risk of limb amputation is 30% and five-year all-cause mortality is 50%, similar to various advanced forms of cancer. Recognition and management are essential to reducing the limb and life loss sequela.
Management of these high-risk individuals is shared between primary care (diagnosis, treatment of cardiovascular risk-factors, rehabilitation) and secondary care (vascular reconstruction, amputation, specialist management of cardiovascular disease).
This mutli-centre prospective cohort study will investigate the explore the educational experience of UK primary care health practitioners for peripheral arterial disease (PAD), including identification of factors that shape their preferred learning style and assess health professionals opinions of PAD recognition and management.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Educational Screening tool
Time frame: 10 years
Educational exposure do primary care health practitioners experience regarding PAD
Time frame: 10 years
What opinions do UK primary care health practitioners have towards PAD recognition and management?
Time frame: 10 years
What factors are important when considering educational interventions to healthcare practitioners in primary care?
University of Leicester
Other
To Explore the Educational Experience of UK Primary Care Health Practitioners for Peripheral Arterial Disease (PAD), Including Identification of Factors That Shape Their Preferred Learning Style and Assess Health Professionals Opinions of PAD Recognition and Management
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05858905
Arterial Occlusive Diseases, Arteriosclerosis
Palo Alto, California, United States
View Trial DetailsNCT05009862
Arterial Occlusive Diseases, Arteriosclerosis
Nashville, Tennessee, United States
View Trial DetailsNCT04130737
Arterial Occlusive Diseases, Arteriosclerosis
Mesa, Arizona, United States
View Trial DetailsNCT04283565
Arterial Occlusive Diseases, Arteriosclerosis
Saint-Etienne, France
View Trial Details